InvestorsHub Logo
Followers 840
Posts 120461
Boards Moderated 18
Alias Born 09/05/2002

Re: None

Friday, 09/30/2016 8:20:09 AM

Friday, September 30, 2016 8:20:09 AM

Post# of 768
ABBV/ENTA's second-generation HCV regimen gets FDA BTD for GT1 DAA-treatment failures:

#msg-125491435

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABBV News